Cargando…

Letter Regarding “Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial”

Detalles Bibliográficos
Autores principales:	Aoki, Yuki, Kataoka, Yuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263251/ https://www.ncbi.nlm.nih.gov/pubmed/35812295 http://dx.doi.org/10.1016/j.ekir.2022.01.1075

Ejemplares similares

In Reply to “Letter Regarding ‘Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial’”
por: Inaba, Masaaki, et al.
Publicado: (2022)

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial
por: Inaba, Masaaki, et al.
Publicado: (2021)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
por: Nitta, Kosaku, et al.
Publicado: (2023)

Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
por: Wish, Jay B.
Publicado: (2023)

Corrigendum to Inaba M, Une Y, Ikejiri K, et al. “Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial.” Kidney Int Rep. 2022;7:177–188
Publicado: (2022)

Long-term safety and decrease of pill burden by tenapanor therapy: a phase 3 open-label study in hemodialysis patients with hyperphosphatemia
por: Koiwa, Fumihiko, et al.
Publicado: (2023)

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
por: Silva, Arnold L., et al.
Publicado: (2023)

Hyperphosphatemia is not significantly associated with increased all-cause mortality in Korean hemodialysis patients
por: Wakasugi, Minako, et al.
Publicado: (2018)

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
por: Akizawa, Tadao, et al.
Publicado: (2021)

Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding
por: Kitajima, Yukie, et al.
Publicado: (2011)

Letter to the Editor Regarding “The COVID-19 Pandemic and Global Neurosurgery: The Situation in Japan and the Philippines”
por: Maiguel-Lapeira, Juan David, et al.
Publicado: (2021)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

In Reply to the Letter to the Editor Regarding “The COVID-19 Pandemic and Global Neurosurgery: The Situation in Japan and the Philippines”
por: Ferraris, Kevin Paul, et al.
Publicado: (2021)

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study
por: Johansson, Susanne A., et al.
Publicado: (2017)

Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis
por: Vasantha, J., et al.
Publicado: (2011)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study
por: Koiwa, Fumihiko, et al.
Publicado: (2016)

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
por: Sakaguchi, Yusuke, et al.
Publicado: (2014)

Regarding the letter from Roxburgh, et al.
por: Gross, RH, et al.
Publicado: (2020)

NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients
por: Maruyama, Sonomi, et al.
Publicado: (2020)

Letter regarding “Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning”
por: de Vries, Frank
Publicado: (2020)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter regarding “ACVIM consensus statement on pancreatitis in cats”
por: Kook, Peter, et al.
Publicado: (2021)

Letter regarding "ACVIM consensus statement on pancreatitis in cats"
por: Törner, Katrin, et al.
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Level of Depression and Anxiety on Quality of Life Among Patients Undergoing Hemodialysis [Letter]
por: Ali, Anumta, et al.
Publicado: (2023)

Letter Regarding “Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios”
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
por: Chu, Chia-Ming, et al.
Publicado: (2023)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
por: Zeng, Qian, et al.
Publicado: (2023)

In Regard to Kil et al
por: Wada, Yuki, et al.
Publicado: (2023)

Letter Regarding Article, "Biventricular Takotsubo Cardiomyopathy Associated with Epilepsy"
por: Madias, John E.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jht32c5lj97hp01abs5hr3ngri